Is a Single Initial Procalcitonin Test Sufficient in Septic, Critically Ill Patients to Minimize Antibiotic Use?
Chest
.
2017 Jul;152(1):218-219.
doi: 10.1016/j.chest.2017.03.062.
Authors
Jos A H van Oers
1
,
Evelien de Jong
2
,
Albertus B Beishuizen
3
,
Maarten W Nijsten
4
,
Armand R Girbes
2
,
Dylan W de Lange
5
Affiliations
1
Department of Intensive Care Medicine, Elisabeth-TweeSteden Ziekenhuis, Tilburg, the Netherlands. Electronic address: jah.vanoers@etz.nl.
2
Department of Intensive Care Medicine, VU University, Medical Center, Amsterdam, the Netherlands.
3
Department of Intensive Care Medicine, Medisch Spectrum Twente, Enschede, the Netherlands.
4
Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
5
Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
PMID:
28693771
DOI:
10.1016/j.chest.2017.03.062
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents
Calcitonin
Critical Illness*
Humans
Procalcitonin*
Protein Precursors
United States
Substances
Anti-Bacterial Agents
Procalcitonin
Protein Precursors
Calcitonin